Sex and Gender Womens Health Collaborative
  • HOME
  • Sex Matters
    • Historical Perspective
    • Research Policies
    • Non Gamstop Casinos Uk
    • Online Casinos
    • Non Gamstop Casinos
  • Resources
    • SGBM Practitioner Registry
    • Curriculum/Training
    • Teaching Tools
    • Presentations
    • Reports/Guidelines
    • Journal Articles
    • Newsletters
    • Recommended Links
  • Professional Education
    • SGBM Practitioner Registry
    • Case Studies
    • Online Courses
    • Medical Meetings
    • Recommended Books
    • Webinars
  • Blog
  • Participate
    • Founding Partners
    • Collaborators
    • Women’s Health Affiliations
    • Support
  • About
    • Vision and Mission
    • Bylaws
    • Programs & Projects
    • Sex & Gender News
    • BOARD OF DIRECTORS
    • Peer Review Policy
    • Disclaimer
  • Contact Us
  • Home
  • Resources
  • Guidelines/Statements
  • Assuring Women Considered for Medical Devices

Resources

  • SGBM Practitioner Registry
  • Curriculum/Training
  • Teaching Tools
  • Presentations
  • Reports/Guidelines
  • Journal Articles
  • Newsletters
  • Recommended Links

Tags

Autoimmune brain Cancer Cardiology Cardiovascular disease clinical care clinical research Cognition cognitive function CVD Depression diabetes diet Emergency Medicine Endocrinology FDA Genetics health care heart disease hypertension inflammatory diseases IOM medical devices medical education medication Mental Health Musculoskeletal Neurology NIH Nutrition Obesity Oncology Osteoporosis pain Pharmacology psychiatry Psychology psychosocial research research reporting Sleep stroke SWHR Women's Health Women's Health

Assuring Women Considered for Medical Devices

January 23, 2014 / SGWHC Editorial Team / Guidelines/Statements, Reports/Guidelines
0

Enrollment and Monitoring of Women in Post-Approval Studies for Medical Devices Mandated by the Food and Drug Administration

Ellen Pinnow, MS, Naomi Herz, BS, Nilsa Loyo-Berrios, PhD, and Michelle Tarver, MD, PhD

Women may respond differently to medical devices due to factors such as genetics, body size, hormones, or other intrinsic sex-specific or extrinsic societal or environmental factors. They may face greater or lesser risk of adverse events or derive more or less benefit. In response, the FDA implemented new procedures to ensure participation by sex is evaluated in PAS reviews.

Download (PDF, Unknown)

 

 

FDA, medical devices

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Busting 5 Common Myths About FDA and Women’s Health
  • Sex and Gender in Acute Care Medicine
  • Gender Medicine: The Groundbreaking New Science of Gender- and Sex-Based Diagnosis and Treatment
  • Colorectal Cancer in Women
  • Sex Differences in Chronic Pain

Recent Comments

  • hoodiebuddies on Sex specific risks of heart disease and cognition
  • MartinGriffi on In This Case: Assessing the Altered Mental Status of an Elderly Patient
  • latina on Sex Differences in Sexually Transmitted Infections

Receive SGWHC Updates

Would you like to receive our newest articles as soon as they are posted? Just give us your email address in the sign-up box on our Home page.

See our Disclaimer to assure that we won't share your address.

Read Our Newsletter

Read our latest (and archived) Newsletters.

Contact Us

  • 269.207.3426
  • [email protected]
  • Contact Us
    • YouTube
    • Twitter
    • Facebook
    • Linkedin
  • Home
  • Contact Us
  • Blog
  • Medical Meetings
  • Resources
  • Newsletters
  • Disclaimer
(c) 2015 Sex and Gender Womens Health Collaborative
  • Facebook
  • Linkedin
  • Twitter
  • YouTube
  • RSS